Search research articles
Contact Us
Filters
Showing results (51-60 of 134) with videos related to
Page
of 14
Sort By:
Journal of Endodontics
|
July 30, 2020
Morphologic Changes of Apical Foramen and Microcrack Formation after Foraminal Enlargement: A Scanning Electron Microscopic and Micro-computed Tomographic Analysis
Maria Lúcia Oliveira Vieira, Hugo Victor Dantas, Frederico Barbosa de Sousa, et al.
The Oncologist
|
May 26, 2018
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study
Jaume Capdevila, Alexandre Teulé, Jorge Barriuso, et al.
Oncotarget
|
August 14, 2014
A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer
Mireia Berdiel-Acer, Antoni Berenguer, Rebeca Sanz-Pamplona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors
Hans Gelderblom, Ramon Salazar, Jaap Verweij, et al.
Molecular Oncology
|
May 21, 2014
Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information
Mireia Berdiel-Acer, Rebeca Sanz-Pamplona, Alexandre Calon, et al.
Neuroendocrinology
|
February 22, 2007
Rare functioning pancreatic endocrine tumors
Dermot O'Toole, Ramon Salazar, Massimo Falconi, et al.
Journal of Neuroendocrinology
|
August 9, 2025
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract
Mairéad G McNamara, Halfdan Sorbye, Nehara Begum, et al.
Cancer Chemotherapy and Pharmacology
|
March 13, 2008
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms
Albert Font, Ramon Salazar, Joan Maurel, et al.
Oncotarget
|
August 13, 2016
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
Samuel Gonçalves-Ribeiro, Natalia Guillen Díaz-Maroto, Mireia Berdiel-Acer, et al.
Carcinogenesis
|
April 25, 2014
Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis
Adria Closa, David Cordero, Rebeca Sanz-Pamplona, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 134) with videos related to
Sort By:
Page
of 14
Journal of Endodontics
|
July 30, 2020
Morphologic Changes of Apical Foramen and Microcrack Formation after Foraminal Enlargement: A Scanning Electron Microscopic and Micro-computed Tomographic Analysis
Maria Lúcia Oliveira Vieira, Hugo Victor Dantas, Frederico Barbosa de Sousa, et al.
The Oncologist
|
May 26, 2018
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study
Jaume Capdevila, Alexandre Teulé, Jorge Barriuso, et al.
Oncotarget
|
August 14, 2014
A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer
Mireia Berdiel-Acer, Antoni Berenguer, Rebeca Sanz-Pamplona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors
Hans Gelderblom, Ramon Salazar, Jaap Verweij, et al.
Molecular Oncology
|
May 21, 2014
Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information
Mireia Berdiel-Acer, Rebeca Sanz-Pamplona, Alexandre Calon, et al.
Neuroendocrinology
|
February 22, 2007
Rare functioning pancreatic endocrine tumors
Dermot O'Toole, Ramon Salazar, Massimo Falconi, et al.
Journal of Neuroendocrinology
|
August 9, 2025
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract
Mairéad G McNamara, Halfdan Sorbye, Nehara Begum, et al.
Cancer Chemotherapy and Pharmacology
|
March 13, 2008
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms
Albert Font, Ramon Salazar, Joan Maurel, et al.
Oncotarget
|
August 13, 2016
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
Samuel Gonçalves-Ribeiro, Natalia Guillen Díaz-Maroto, Mireia Berdiel-Acer, et al.
Carcinogenesis
|
April 25, 2014
Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis
Adria Closa, David Cordero, Rebeca Sanz-Pamplona, et al.
Page
of 14